COVID-19

Vaccine effectiveness was slightly lower in patients with underweight, who also have the lowest levels of vaccine uptake across all ages.

According to the results, individuals with SCT who previously had COVID-19 also had various preexisting kidney conditions that were associated with poor outcomes.

The increase was highest for Hispanic and non-Hispanic Black Women.

There was increased PTSD scores found in doctor and nurse responders.

Study investigators aimed to raise awareness of the potential risk of retinal vascular events associated with COVID-19 infection.

The FDA amended the EUA to include the use of Moderna in individuals 6 months through 17 years of age and Pfizer in those 6 months through 4 years of age.

Dr. Aric Prather discusses the pandemic, his research, and his presentation from SLEEP 2022 "Sleep in the Time of COVID: An Update on How Sleep Affects the Immune System".

There are still many aspects of sleep health that need to be understood, especially in relation to the COVID-19 pandemic.

Even after controlling for differences in age and BMI, investigators observe a greater burden of sleep health on those who had severe COVID-19 versus the general population.

Dr. Aric Prather and his team at UCSF are running a large study that began in March 2021 which follows healthy individuals through the COVID-19 vaccination and booster process.

Sleep expert Aric Prather, PhD, presented a discussion at SLEEP 2022 that focused on how the immune system and sleep are related to the "ongoing and protracted" impact of the COVID-19 pandemic.

Primary care provider Dr. Gerald Smetana shares key information and resources to give PCPs all they need know about prescribing outpatient therapies for COVID-19.

APA president-elect Rebecca W. Brendel, MD, JD, discusses the need to prepare for a "twin mental health pandemic" while continuing to appropriately facilitate innovations in psychiatric care.

New data suggest pediatric patients with a history of cardiac arrest are highly susceptible to hospitalization if infected with SARS-CoV-2.

Investigators in a new multicenter study observed poor vaccine-induced serological responses in patients treated with infliximab or tofacitinib.

New data suggest prediction of SARS-CoV-2 and bacterial co-infection or superinfection could be provided for hospitalized patients.

Dr. Gerald Smetana encourages PCPs to familiarize themselves with the outpatient drug options for managing COVID-19 because of the limited treatment window for administration.

Dr. Tara Vijayan talks about how primary care physicians can be best combat misinformation.

High-risk individuals should be targeted when drug scarcity comes into play.

Dr. Tara Vijayan speaks on improving COVID-19 treatment from “an equity standpoint, an ethical standpoint, and an evidence standpoint”.

There remains a need to develop more antivirals that can be easily scaled up for COVID-19.

These findings suggest the importance of COVID-19 vaccination for patients with OHT.

There is concern for cardiovascular patients over missed screenings during the pandemic.

Females were disproportionately affected by some of the restrictions put in place in the early stages of the COVID-19 pandemic.

The company reported interim results at a meeting this week showing multiple formulations were tolerable and safe. Next comes a phase 2 trial.